
Mecowast Trio 75mg/10mg/1500mcg Tablet SR
Marketer
Aplonis Healthcare
Salt Composition
Pregabalin (75mg) + Nortriptyline (10mg) + Methylcobalamin (1500mcg)
Overview Mecowast Trio 75mg/10mg/1500mcg Tablet SR
TriNeuromin 75mg/10mg/1500mcg Extended-Release Tablets are a triple-action formulation for neuropathic pain management. This medication reduces pain signals by modulating nerve cell calcium channels. It also boosts brain neurotransmitters that improve mood and safeguard nerve health. TriNeuromin may be administered with or without food, but consistent daily timing ensures stable drug levels. Always follow your physician's prescribed dosage and duration. Missed doses should be taken promptly upon recollection. Complete the entire treatment course, even with symptom improvement. Abrupt cessation may exacerbate symptoms. Common side effects include constipation, weight increase, and dry mouth. Dizziness and drowsiness are possible; avoid driving or tasks requiring alertness until the drug's effects are known. Weight gain may occur; maintain a healthy diet and regular exercise. Report any unusual mood shifts, worsening depression, or suicidal ideation to your doctor immediately. Prior to commencing treatment, disclose any kidney or liver conditions, and list all other medications you are currently using, as interactions may affect efficacy. Inform your doctor if you are pregnant, intend to become pregnant, or are breastfeeding.
Uses of Mecowast Trio 75mg/10mg/1500mcg Tablet SR
Managing neuropathic pain
Major Benefits of Mecowast Trio 75mg/10mg/1500mcg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the Mecowast Trio 75mg/10mg/1500mcg Tablet SR whole; avoid chewing, crushing, or fracturing the tablet. Consumption may coincide with meals or be taken independently, although consistent daily timing is recommended.
Common Side effects of Mecowast Trio 75mg/10mg/1500mcg Tablet SR:
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Increased heart rate
- Difficulty in urination
- Decreased appetite
- Nausea
- Vomiting
- Constipation
- Weight gain
- Dizziness
- Sleepiness
- Tiredness
- Blurred vision
- Dryness in mouth
- Uncoordinated body movements
- Diarrhea
- Headache
How to use Mecowast Trio 75mg/10mg/1500mcg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the Mecowast Trio 75mg/10mg/1500mcg Tablet SR whole; avoid chewing, crushing, or fracturing the tablet. Consumption may coincide with meals or occur independently, however, consistent daily timing is recommended.
How Mecowast Trio 75mg/10mg/1500mcg Tablet SR works:
Mecowast Trio 75mg/10mg/1500mcg extended-release tablets contain pregabalin, nortriptyline, and methylcobalamin. Pregabalin, an alpha-2-delta calcium channel ligand, reduces pain by altering nerve cell calcium channel function. Nortriptyline, a tricyclic antidepressant, elevates serotonin and noradrenaline levels, thus inhibiting pain signal transmission in the brain. Methylcobalamin, a B vitamin, supports myelin production, protecting nerve fibers and promoting nerve cell repair. This synergistic combination offers relief from the discomfort of neuropathic pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Mecowast Trio 75mg/10mg/1500mcg sustained-release tablets and alcohol may result in heightened sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Mecowast Trio 75mg/10mg/1500mcg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The extended-release Mecowast Trio 75mg/10mg/1500mcg tablet is likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Mecowast Trio 75mg/10mg/1500mcg Tablet SR, due to potential side effects that can reduce alertness.
KidneyCAUTION
Patients with kidney impairment should use Mecowast Trio 75mg/10mg/1500mcg Tablet SR cautiously. Dosage modification of Mecowast Trio 75mg/10mg/1500mcg Tablet SR might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Mecowast Trio 75mg/10mg/1500mcg Tablet SR in patients with liver disease appears to pose minimal risk. Available evidence indicates dose modification may be unnecessary, however, physician consultation is recommended.
What if you forget to take Mecowast Trio 75mg/10mg/1500mcg Tablet SR :
Should you forget a Mecowast Trio 75mg/10mg/1500mcg SR Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Mecowast Trio 75mg/10mg/1500mcg Tablet SR
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Treatment Category | Nervous system medications. |
